SavedAdd your journal

Journals / Selçuk Tıp Dergisi / 2006 / Cilt: 22 - Sayı: 3

The evaluation of risk factors in ischemic stroke

İskemik inmede risk faktörlerinin değerlendirilmesi

Mehmet GÜL
Metin BİRCAN
A. Sadık GİRİŞGİN
BAŞAR CANDER
H. Hüseyin KOZAK
Pages
103–106
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Diabetes mellitus and dyslipidemia have not been found as significant risk factors in patients with stroke when compared with the control group (P>0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to contribute to the data about the ischemic stroke epidemiology.
📊
Key Findings & Data:Material and method: We analyzed 99 patients with ischemic stroke regarding the stroke risk factors.
💡
Conclusion & Impact:Conclusion: Diabetes mellitus and dyslipidemia have not been found as significant risk factors in patients with stroke when compared with the control group (P>0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study was to contribute to the data about the ischemic stroke epidemiology. Material and method: We analyzed 99 patients with ischemic stroke regarding the stroke risk factors. The patients and the controls were compared in respect to stroke risk factors. Results: Hypertension, atrial fibrillation, and cigarette smoking was statistically significant as a risk factor in the stroke group compared with the control group (P<0.05). Conclusion: Diabetes mellitus and dyslipidemia have not been found as significant risk factors in patients with stroke when compared with the control group (P>0.05).

Özet

Amaç: Bu çalışmanın amacı iskemik inme epidemiyolojisi ile ilgili verilere katkıda bulunmaktı. Gereç ve Yöntem: Biz iskemik inme tanısı almış 99 olguyu inme risk faktörleri yönünden inceledik. Hasta ve kontrol grubu inme risk faktörleri açısından karşılaştırıldı. Bulgular: Hipertansiyon (HT), atriyal fibrilasyon (AF) ve sigara; iskemik inmeli olgularda risk faktörleri olarak kontrol grubuna göre istatistiksel olarak anlamlı bulundu (P 0.05).

🔖

Cite This Article

GÜL, M., BİRCAN, M., GİRİŞGİN, A. S., CANDER, B., KOZAK, H. H. (2006). The evaluation of risk factors in ischemic stroke. Selçuk Tıp Dergisi, Cilt: 22 - Sayı: 3, 103–106. https://ajindex.com/articles/319619

References (16)

  1. Kumral E, Balkır K. İnme epidemiyolojisi. Balkan S (Ed). Serebrovasküler Hastalıklar. Güneş Kitabevi Yayınları, Ankara, 2002. 38-48
  2. Lewandowski C, Barsan W. Treatment of acute ischemic stroke. Ann Emerg Med. 2001;37:202-16. 3. de Freitas GR, Bogousslavsky J. Primary stroke prevention. European Journal of Neurology. 2001;8:1- 15
  3. Utku U, Çelik Y. İnmede etyoloji, sınıflandırma ve risk faktörleri. Balkan S (Ed). Serebrovasküler Hastalıklar. Güneş Kitabevi Yayınları, Ankara, 2002. 49-61
  4. Hervas A. Stroke risk factors. Population case-control study in the Foral Community of Navarre. An Sist Sanit Navar 2005;28:325-34
  5. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52
  6. Hearth Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE subs-tudy. Lancet 2000;355:253-9
  7. Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Total homocysteine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Stroke 1998;29:2473-7
  8. Kitagawa Y. Antiphospholipid syndrome and stroke. Rinsho Shinkeigaku. 2005;45:852-5
  9. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94
  10. Petitti DB, Sidney S, Quesenberry CP Jr, Bernstein A. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke 1998;29:23-8
  11. Yamashita K, Ouchi K, Shirai M, Gondo T, Nakazawa T, Ito H. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke. 1998;29:773-8
  12. Gil de Castro R, Gil-Nunez AC. Risk factors for ischemic stroke. Conventional risk factors Rev Neurol. 2000;3:314-23
  13. Warlow CP. Epidemiology of stroke. Lancet 1998;352:1-4
  14. Jensen MB, Yoo B, Clarke WR, Davis PH, Adams HR Jr. Blood pressure as an independent prognostic factor in acute ischemic stroke. Can J Neurol Sci. 2006;33:34-8
  15. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43:18-24
  16. Ueshima H, Choudhury SR, Okayama A, Hayakawa T, Kita Y, Kadowaki T, Ok